Tibau A - Search Results

1

Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review.

Salazar J, Bracchiglione J, Savall-Esteve O, Antequera A, Bottaro-Parra D, Gutiérrez-Valencia M, Martínez-Peralta S, Pericay C, Tibau A, Bonfill X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Salazar J, et al. Among authors: tibau a. BMC Cancer. 2023 Aug 12;23(1):748. doi: 10.1186/s12885-023-11207-4. BMC Cancer. 2023. PMID: 37573294 Free PMC article.

2

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.

Tibau A, Molto C, Ocana A, Templeton AJ, Del Carpio LP, Del Paggio JC, Barnadas A, Booth CM, Amir E. Tibau A, et al. J Natl Cancer Inst. 2018 May 1;110(5):486-492. doi: 10.1093/jnci/djx232. J Natl Cancer Inst. 2018. PMID: 29244173

3

Response.

Tibau A, Molto C, Amir E. Tibau A, et al. J Natl Cancer Inst. 2018 Oct 1;110(10):1145. doi: 10.1093/jnci/djy031. J Natl Cancer Inst. 2018. PMID: 29529214 No abstract available.

4

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials.

Tibau A, Molto C, Borrell M, Del Paggio JC, Barnadas A, Booth CM, Amir E. Tibau A, et al. JAMA Oncol. 2018 Nov 1;4(11):1610-1611. doi: 10.1001/jamaoncol.2018.4300. JAMA Oncol. 2018. PMID: 30267037 Free PMC article.

5

Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment.

Gyawali B, Hwang TJ, Vokinger KN, Booth CM, Amir E, Tibau A. Gyawali B, et al. Among authors: tibau a. Am Soc Clin Oncol Educ Book. 2019 Jan;39:374-387. doi: 10.1200/EDBK_242229. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099613 Free article.

6

Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration.

Molto C, Hwang TJ, Borrell M, Andres M, Gich I, Barnadas A, Amir E, Kesselheim AS, Tibau A. Molto C, et al. Among authors: tibau a. Cancer. 2020 Oct 1;126(19):4390-4399. doi: 10.1002/cncr.33095. Epub 2020 Jul 22. Cancer. 2020. PMID: 32697362 Free article.

7

National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional study.

Etan T, Amir E, Tibau A, Yerushalmi R, Moore A, Shepshelovich D, Goldvaser H. Etan T, et al. Among authors: tibau a. Cancer Treat Rev. 2020 Dec;91:102113. doi: 10.1016/j.ctrv.2020.102113. Epub 2020 Oct 20. Cancer Treat Rev. 2020. PMID: 33128993 Review.

8

Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations.

Wilson BE, Desnoyers A, Nadler MB, Tibau A, Amir E. Wilson BE, et al. Among authors: tibau a. Cancer Med. 2021 Aug;10(16):5405-5414. doi: 10.1002/cam4.4029. Epub 2021 Jul 28. Cancer Med. 2021. PMID: 34323019 Free PMC article.

9

The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemic review and meta-analysis.

Dabush DR, Shepshelovich D, Shochat T, Tibau A, Amir E, Goldvaser H. Dabush DR, et al. Among authors: tibau a. Cancer Treat Rev. 2021 Nov;100:102293. doi: 10.1016/j.ctrv.2021.102293. Epub 2021 Sep 13. Cancer Treat Rev. 2021. PMID: 34543860

10

Clinical benefit of cancer drugs approved in Switzerland 2010-2019.

Adam R, Tibau A, Molto Valiente C, Šeruga B, Ocaña A, Amir E, Templeton AJ. Adam R, et al. Among authors: tibau a. PLoS One. 2022 Jun 10;17(6):e0268545. doi: 10.1371/journal.pone.0268545. eCollection 2022. PLoS One. 2022. PMID: 35687539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page